KleinkeJD Kleinke and Omnimedix are still in business and still fighting a pretty serious lawsuit
about the Dossia breakup. I talked with JD yesterday. The team is working on several super secret client projects, but it’s tough to run a small consulting shop and keep a protracted lawsuit open, so they’re passing the hat! Why keep the lawsuit going?

Well, there’s obviously stuff that JD couldn’t tell me, so this is speculation but it’s clear that this is much more than an a “vendor didn’t deliver/client didn’t pay” dispute. JD was always very vocal about an open nonprofit being the protector of the Dossia members’ employees’ data, so I surmise that contractual disputes about who got access to what data are at the root of this. It would be interesting (if practicably impossible) to compare Dossia’s contact with Omnimedix in their contract with Indivo.

More generally, JD and I talked about whether there’s a need for a Dossia-type entity when there’s Google Health and HealthVault. Here’s what JD said about Microsoft and Google’s privacy stance.

“In both cases they’ve violated their own operating principles as businesses to do the right thing.”

But while he likes their model and has lots of respect for their
credibility on privacy JD suggests one more thing—they need to be
interoperable with each other. Then they’d both be able to share each
other’s partnerships. (You’ll be hearing more about this at Health 2.0.)

Finally, I asked JD that with Healthvault, Google Health and others
out there, if there was still a need for a nonprofit unaffliliated
with employers to provide a nationwide PHR. He said yes
and thinks some people won’t trust any corporation and that
Ominmedix could still build the read-only interface into every source
of health data for a mere $15 million.

Will we see a Foundation bite? I wonder, but many have wasted lots more money on less worthwhile ventures.

1 Response for “Omnimedix still fighting Dossia owners”

  1. Oh Boy,
    JD sounds more delusional than I could ever imagine. Frankly, never did understand why Dossia partnered with Omnimedix in the first place as Omnimedix had no past experience with building such a platform, no track record. Why anyone would partner with an entity like that is beyond me, unless of course there was some back-room deal and seeing as the founders of Omnimedix did come from Intel, well…

Leave a Reply

THCB ADS





MASTHEAD


Matthew Holt
Founder & Publisher

John Irvine
Executive Editor

Jonathan Halvorson
Editor

Alex Epstein
Director of Digital Media

Munia Mitra, MD
Editor, Business of Healthcare

Laura Montini
Associate Editor

Cindy Williams
Associate Editor

Michael Millenson
Contributing Editor










About Us | Media Guide
© THCB 1995-2012
WRITE FOR US

We're looking for bloggers. Send us your posts.

If you've had a recent experience with the U.S. health care system, either for good or bad, that you want the world to know about, tell us.

Have a good health care story you think we should know about? Send story ideas and tips to tips@thehealthcareblog.com.

ADVERTISE

Want to reach a dedicated audience of healthcare insiders and industry observers? THCB reaches a monthly audience of 100,000 movers and shakers. We reach a total circulation of roughly 450,000. Find out about advertising options here.

Questions on reprints, permissions and syndication to ad_sales@thehealthcareblog.com.

THCB CLASSIFIEDS

Reach a super targeted healthcare audience with your text ad. Target physicians, health plan execs, health IT and other groups with your message.
ad_sales@thehealthcareblog.com
WORK FOR US:

Interested in the intersection of healthcare, technology and business? We're looking for talented interns to work in our San Francisco offices. Get in touch.

Wordpress guru? We're looking for a part time web-developer to help take THCB to the next level. Drop us a line.

SUPPORT:

Let us know about a glitch or a technical problem.

Report spam or abuse here.
SEND US STUFF:

THCB
650 Delancey Street
San Francisco, California 94107

Other stuff you can do:

Subscribe to our RSS feed
Get THCB via Email
Follow us on Twitter
Like us on Facebook